酸素療法機器市場- 世界の産業規模、シェア、動向、機会、予測、2018年～2028年製品タイプ別、モビリティ別、用途別、エンドユーザー別、地域別、競合別に区分

2022年、世界の酸素療法機器市場の評価額は108億3,000万米ドルに達し、予測期間中は目覚ましい成長を示し、2028年まで6.22%のCAGR（年間平均成長率）を維持する見通しです。

酸素療法は、十分な酸素濃度の維持が必要な患者にとって極めて重要な治療法です。酸素療法は、喘息、慢性閉塞性肺疾患（COPD）、睡眠時無呼吸症候群など、患者への酸素供給不足を特徴とする病態の管理に一般的に用いられています。

患者は、酸素濃縮器、液体酸素、高気圧酸素療法など、それぞれの必要性に応じてさまざまな種類の酸素療法を受けることができます。医療介入としての酸素療法は，急性または慢性の患者ケアに酸素ガスを利用し，多様な細胞代謝プロセスをサポートし，組織の酸素化を通じて最適な生理機能を促進する上で重要な役割を果たします。

酸素療法は，血中酸素濃度が必要な閾値を下回った場合に必要となります。酸素療法は、経鼻投与から閉鎖環境下で行う高気圧酸素療法まで、さまざまな方法で行うことができます。肺、鼻腔、気管からなる呼吸器系は、呼吸のプロセスを促進します。空気は鼻または口から体内に入り、気管を通って気管支から肺に達します。酸素療法機器は、酸素を濃縮した空気を安定して供給するための信頼できる装置です。これらの装置は周囲の空気を効果的にろ過し、ほこり、細菌、その他の微粒子を除去することで、供給される酸素の純度を確保します。

市場促進要因

最新の酸素療法ソリューションの急増

最もマイナーで耐久性のあるポータブル酸素ソリューションへの需要が高まっています。患者は、コンパクトで長持ちするだけでなく、持ち運びも簡単な酸素療法オプションを求めるようになっています。このような嗜好は、重くて厄介な酸素装置を持ち歩く負担を避けたいという願望から生じています。幸いなことに、近年、酸素を節約する方法やリチウムイオン電池の技術が大きく進歩し、特に電池の寿命が向上しています。

タバコ喫煙の増加

喫煙に関連した健康問題は世界的に公衆衛生上の大きな懸念であり続けているため、タバコ喫煙の増加が酸素療法機器の需要を押し上げると予想されます。喫煙は、慢性閉塞性肺疾患（COPD）や肺がんを含むさまざまな呼吸器疾患の主な原因であり、治療・管理計画の一環として酸素療法が必要となることが多いです。

COPDは、一般的に喫煙に関連する進行性の肺疾患であり、効率的に呼吸する能力に深刻な影響を与えます。症状が悪化すると酸素欠乏症になることが多く、適切な血中酸素濃度を維持するために酸素補充療法が必要となります。喫煙によるCOPD患者の増加に伴い、罹患者の生活の質を向上させるために、酸素濃縮器、携帯用酸素ボンベ、その他の酸素供給システムの必要性が高まっています。

さらに、喫煙は肺がんの重大な危険因子であり、肺がん治療を受けている患者は症状や副作用を管理するために酸素療法を必要とする場合もあります。喫煙習慣が原因で肺がんの罹患率が世界的に上昇を続けているため、酸素濃縮器や酸素マスクといった酸素療法機器の需要も連動して増加するとみられます。タバコ喫煙に関連した健康状態の増加は、罹患者の管理と生活改善に酸素療法機器が果たす重要な役割を強調しています。喫煙に関連する呼吸器疾患は世界の健康上の大きな課題となっているため、酸素療法機器の需要は拡大すると予想され、この重要な医療分野における継続的な進歩と革新が必要となります。

呼吸器疾患の有病率の上昇

呼吸器系疾患の有病率の上昇は、酸素療法機器の需要を大幅に増加させることが予想され、現代ヘルスケアの重要な側面となっています。慢性閉塞性肺疾患（COPD）、喘息、肺炎、間質性肺疾患などの呼吸器疾患は世界的に増加傾向にあり、症状を管理し患者のQOLを向上させるために酸素療法が必要となることが多いです。

COPDのような慢性呼吸器疾患は、特に大気汚染、喫煙、高齢化などの要因により、公衆衛生上の大きな問題となっています。COPD患者はしばしば呼吸困難を経験し、適切な血中酸素濃度を維持するために補助酸素を必要とします。この人口の増加により、酸素濃縮器、携帯用酸素ボンベ、その他の酸素供給システムの需要が増加しています。

もう一つの一般的な呼吸器疾患である喘息は、世界中で数百万人が罹患しており、重度の喘息発作は酸素欠乏につながる可能性があります。喘息の急性増悪時に患者を安定させるためには酸素療法が不可欠であることが多く、酸素関連機器の需要をさらに高めています。COVID-19パンデミックは、世界中の病院が重度の呼吸器症状を持つ患者の急増に直面したことから、酸素療法機器の重要性も浮き彫りにしました。このため、ヘルスケア施設に十分な酸素インフラを整備する必要性が強調され、酸素濃縮装置と人工呼吸器の需要がさらに強調されました。

さらに、ヘルスケアの動向が在宅医療や遠隔医療にシフトするにつれて、慢性呼吸器疾患を自宅で管理する患者のために、持ち運び可能で使い勝手のよい酸素療法機器の需要が高まっています。

酸素療法における技術の進歩

酸素療法分野における技術の進歩はヘルスケア業界に革命をもたらし、酸素療法機器の需要をかつてないほど急増させる勢いです。こうした技術革新は治療の有効性を向上させるだけでなく、患者の快適性や利用しやすさを向上させ、呼吸器ケアの展望を再構築しています。

重要な発展のひとつに、患者が移動中に酸素療法を自由に受けられる携帯型酸素濃縮器（POC）の普及があります。これらの軽量でコンパクトな装置は、先進的なバッテリー技術を搭載しているため、長時間の稼働が可能であり、患者は活動的なライフスタイルを維持することができ、QOLの向上に貢献します。高齢者人口が増え続ける中、高齢者が自立して地域社会に参加し続けることを可能にするPOCの需要は急増すると予想されます。

さらに、遠隔医療と遠隔モニタリング・ソリューションは、酸素療法管理における強力なツールとして台頭してきています。スマートセンサーとワイヤレス接続の統合により、ヘルスケア専門家は患者の酸素濃度を遠隔地から追跡し、治療計画をリアルタイムで調整し、必要に応じて即座にサポートを提供することができます。これにより、患者の全体的な体感が向上するだけでなく、ヘルスケア施設やスタッフの負担も軽減されます。

主な市場課題

厳しい規制ガイドライン

ヘルスケア業界における厳しい規制ガイドラインは、酸素療法機器の需要を大幅に減少させる可能性があります。規制は患者の安全性と治療効果を確保するために不可欠であるが、過度に複雑で負担の大きい規制環境は、技術革新を妨げ、コストを押し上げ、メーカーやヘルスケアプロバイダーの市場参入を制限する障害を生み出す可能性があります。厳格な規制プロセスは、新しく改良された酸素療法機器の市場導入を遅らせる可能性があります。この遅れは深刻な結果をもたらす可能性があり、患者はより効果的な治療や生活の質を高める技術革新を受けられなくなる可能性があります。また、ヘルスケアプロバイダーは、規制当局の承認に伴う不確実性や複雑さのために新技術の採用を躊躇し、需要をさらに抑制する可能性があります。

さらに、厳格なガイドラインにより、利用可能な機器の選択肢が限られ、業界内の競合やイノベーションが減少する可能性もあります。このような多様性の欠如は、患者やヘルスケア専門家にとっての選択肢を減らし、個々のニーズに最適なソリューションを見つけることを難しくします。規制ガイドラインは患者の安全性と治療効果を確保するために極めて重要であるが、過度に厳しい規制は酸素療法機器の需要を減退させる障壁となりうる。規制と技術革新の間で適切なバランスを取ることは、患者が最も先進的で手頃な価格の呼吸ケアソリューションを利用できるようにするために不可欠です。

頻発する副作用

酸素療法の市場拡大は、治療的に使用される場合、皮膚刺激や鼻の乾燥といった好ましくない副作用によって制約されています。鼻の乾燥と皮膚の炎症は、酸素療法の最も典型的な副作用の2つです。カニューレが皮膚とこすれて炎症を起こすことがあります。

さらに、高濃度の酸素に長時間さらされると、酸素中毒のリスクが高まり、肺だけでなく他の臓器系にも深刻な害を及ぼす可能性があります。不適切な酸素補給や過剰な酸素補給は酸素中毒を引き起こし、肺機能や全身の健康に悪影響を及ぼします。これは肺損傷につながる可能性があり、身体の効果的なガス交換能力を損なう。

さらに、酸素療法によって誘発される肺疾患の範囲は、軽度の気管気管支炎にとどまらず、広範な肺胞損傷にまで及ぶ。高濃度の酸素に長期間さらされることによるフリーラジカルの過剰産生は、さらに肺損傷の一因となり、酸素療法の全体的な効果を妨げます。

これらの要因を考慮すると、酸素療法に伴うこうした副作用や潜在的リスクの存在が、酸素療法機器市場の拡大に課題をもたらす可能性があることが明らかになります。

主要市場動向

治療機器の技術進歩

酸素療法機器（OTD）に依存する呼吸器疾患の患者数が大幅に増加しているため、ヘルスケア施設は常時OTDのサポートを必要とする患者を効果的に管理しなければならないという大きなプレッシャーに直面しています。こうした需要の高まりが酸素療法ソリューション市場を牽引しています。ウェアラブル技術が進歩を続け、光電式容積脈波（PPG）センサーやワイヤレス5G接続が顕著に改善されるにつれて、酸素療法モニタリングのための**デジタルヘルス**データ転送の動向は急速な成長を遂げると予想されます。

PPGは非侵襲的な装置であり、皮膚表面に配置された光源と光検出器を利用して血液循環の体積変動を正確に測定します。ウェアラブルPPGセンサーは、指先、耳たぶ、額など身体の特定部位に快適に装着できます。さらに、遠隔患者モニタリングシステムの利用や導入が増加するにつれて、これらのシステムの使用に関する適切な指導のおかげで、患者はより積極的に自身のケアに関与するようになってきています。こうした進歩と患者の関与は、市場の成長と収益性に有望な見通しをもたらしています。

先進の携帯型酸素ソリューション

携帯型酸素濃縮器（POC）や軽量で装着可能な機器は今後も進化を続けるであろう。これらの技術革新により、患者は活動的なライフスタイルを維持しながら酸素療法を受けられるようになり、さらには旅行にも行けるようになるため、生活の質の向上に貢献することになります。POCは今後も小型軽量化が進み、携帯性に優れるようになります。これらの機器は、バックパックに入れて持ち運んだり、目立たないアクセサリーとして身につけたりすることも容易になります。患者は、かさばる機器に煩わされることなく、自由に動き回ることができるようになります。

バッテリー技術が進歩し、POCの駆動時間が長くなります。これは、患者が充電や電池交換を必要とせずに長時間使用できることを意味し、旅行や屋外での活動をより実用的なものにします。POCにはワイヤレス接続オプションが搭載され、ヘルスケアプロバイダーや介護者による遠隔モニタリングが可能になります。酸素レベルや使用パターンに関するデータをリアルタイムで送信できるため、治療計画をタイムリーに調整し、より良いサポートを提供することが可能になります。これらの進歩により、患者は酸素療法のニーズを管理しながら、より活動的で充実した生活を送ることができるようになります。携帯性、利便性、接続性が向上することで、患者は活動的なライフスタイルを維持し、旅行やさまざまな活動に参加できるようになり、最終的に呼吸器疾患のある人の生活の質の向上に貢献することになります。

セグメント別インサイト

モビリティの洞察

可動性セグメントに基づくと、据え置き型酸素療法機器は可搬性の点で市場を独占すると予測されます。これは主に、治療を受けている患者のかなりの数がベッドに閉じ込められているという事実によるものであり、そのため固定式酸素療法機器市場は主要な牽引役であり、予測期間を通じて市場収益を最大化する要因となっています。

このカテゴリの拡大は、人口基盤の増加、有利な償還政策、患者の移動性の低さなど、いくつかの要因に起因しています。その結果、住宅環境における長期酸素療法（LTOT）機器の需要が増加しており、予測期間を通じて酸素療法機器全体の需要をさらに押し上げるとみられています。住宅環境におけるLTOT機器の利用は、患者に利便性と快適性の向上を提供するだけでなく、患者の生活の質の全体的な向上にも貢献します。

用途別洞察

用途別に見ると、市場は慢性閉塞性肺疾患（COPD）、肺がん、肺炎、COVID-19、その他に二分されます。このうち、慢性閉塞性肺疾患（COPD）分野は、世界的にCOPDの有病率が増加していることから、最大シェアで市場を独占しています。世界保健機関（WHO）の推計によると、現在約6,500万人がCOPDに罹患しており、世界第5位の死因となっています。この憂慮すべき統計は、効果的なCOPD治療に対する緊急の必要性を浮き彫りにし、市場に大きな臨床需要を生み出し、ひいてはこの領域で事業を展開する企業の成長に寄与しています。COPDの有病率の上昇に伴い、この慢性呼吸器疾患に対処し、罹患者の生活の質を改善するための革新的な治療ソリューションの開発にますます注目が集まっています。

地域別洞察

予測期間中、北米は世界の酸素療法機器市場における優位性を維持すると予測されています。これは、COPD、喘息、一酸化炭素中毒などの呼吸器疾患の有病率が増加しているためです。さらに、同地域におけるCOVID-19症例数の増加が、今後数年間の酸素療法機器需要を牽引すると予想されています。

さらに、米国が世界の酸素療法機器市場で最大のシェアを占めているが、その主な理由は、医療インフラが確立されていることと、高度な非侵襲的患者モニタリング技術の採用が拡大していることです。さらに、Koninklijke Philips N.V.、Invacare Corporation、Inogen, Inc.などの主要市場プレイヤーの存在は、酸素療法機器市場をさらに推進すると予想されます。

膨大な患者人口や同地域における新製品のイントロダクションなど様々な要因を考慮すると、北米の酸素療法機器市場は予測期間中に大きな成長を遂げると予測されます。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 酸素療法機器の世界市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品タイプ別（酸素源装置/酸素供給装置）
  • 移動性別（据え置き型/携帯型）
  • 用途別（COPD、肺がん、肺炎、COVID-19、その他）
  • エンドユーザー別（病院・クリニック、外来医療センター、在宅医療、その他）
  • 地域別
  • 企業別（2022年）
• 市場マップ

第6章 北米の酸素療法機器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • モビリティ別
  • アプリケーション別
  • エンドユーザー別
  • 国別
• 北米国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州酸素治療器市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • モビリティ別
  • アプリケーション別
  • エンドユーザー別
  • 国別
• 欧州国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の酸素治療器市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • モビリティ別
  • アプリケーション別
  • エンドユーザー別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米酸素治療器市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • モビリティ別
  • アプリケーション別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの酸素治療器市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • モビリティ別
  • アプリケーション別
  • エンドユーザー別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の展開
• 合併・買収
• 製品発表

第13章 世界の酸素療法機器市場SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Business Overview
• Service Offerings
• Recent Developments
• Key Personnel
• SWOT Analysis
  • Allied Healthcare Products, Inc.
  • CAIRE Inc.
  • DeVilbiss Healthcare
  • Fisher & Paykel Healthcare Limited
  • Inogen Inc.
  • Invacare Corporation
  • Koninklijke Philips N.V.,
  • Smiths Medical, Inc.
  • Taiyo Nippon Sanso Corporation
  • Linde Healthcare

第16章 戦略的提言

第17章 調査会社について・免責事項

In 2022, the Global Oxygen Therapy Equipment Market reached a valuation of USD 10.83 Billion, and it is poised to exhibit impressive growth during the forecast period, maintaining a substantial Compound Annual Growth Rate (CAGR) of 6.22% through 2028. Oxygen therapy stands as a pivotal treatment approach for individuals in need of maintaining adequate oxygen levels. It is commonly employed in the management of conditions such as asthma, Chronic Obstructive Pulmonary Disease (COPD), sleep apnea, and other scenarios characterized by insufficient oxygen supply to patients.

Patients can access various types of oxygen therapy based on their specific requirements, including oxygen concentrators, liquid oxygen, and hyperbaric oxygen therapy. Oxygen therapy, as a medical intervention, harnesses oxygen gas to administer acute or chronic patient care, playing a critical role in supporting diverse cellular metabolic processes and promoting optimal physiological function through tissue oxygenation.

Oxygen therapy becomes necessary when blood oxygen levels are below the required threshold. It can be administered through a range of methods, encompassing nasal delivery to hyperbaric oxygen therapy conducted within a closed environment. The respiratory system, comprising the lungs, nasal passages, and windpipe, facilitates the process of respiration. Air enters the body through the nose or mouth and travels through the windpipe, reaching the lungs via the bronchi. Oxygen therapy equipment serves as a dependable device that ensures a consistent supply of oxygen-enriched air. These devices effectively filter ambient air, removing dust, bacteria, and other particulates, thereby ensuring the purity of the delivered oxygen.

Key Market Drivers

Surge In the Latest Oxygen Therapy Solutions

The demand for the most minor, durable portable oxygen solutions is rising. Patients are increasingly seeking oxygen therapy options that are not only compact and long-lasting but also easy to carry. This preference arises from their desire to avoid the burden of lugging around a heavy and cumbersome oxygen device. Fortunately, recent years have witnessed significant advancements in oxygen-conserving methods and lithium-ion battery technology, particularly in terms of battery life improvement.

The latest versions of portable oxygen concentrators weigh a mere 5-7 pounds. These lightweight devices can provide oxygen therapy for extended periods, ranging from 8 to 13 hours, depending on the litre flow settings chosen by each patient, after a single battery charge. The focus of manufacturers has also shifted towards developing silent compressor motors for these concentrators, thereby reducing noise pollution in small and confined spaces.

Moreover, the effective utilization of dosing technology has enabled portable oxygen concentrator manufacturers to enhance their products' performance features. This, in turn, has resulted in current designs that offer a longer lifespan beyond occasional use, making them more reliable and durable for a consistent five-year cycle. With these advancements and improvements, patients can now enjoy the benefits of portable oxygen therapy without compromising on convenience, reliability, and longevity.

Increase in Tobacco Smoking

The increase in tobacco smoking is expected to drive up the demand for oxygen therapy equipment, as smoking-related health issues continue to be a major public health concern worldwide. Smoking is a leading cause of various respiratory conditions, including chronic obstructive pulmonary disease (COPD) and lung cancer, which often necessitate oxygen therapy as part of the treatment and management plan.

COPD, a progressive lung disease commonly linked to smoking, can severely impact a person's ability to breathe efficiently. As the condition worsens, individuals often experience oxygen deficiency, requiring supplemental oxygen therapy to maintain adequate blood oxygen levels. With the rising number of COPD cases due to smoking, there is a growing need for oxygen concentrators, portable oxygen tanks, and other oxygen delivery systems to improve the quality of life for affected individuals.

Moreover, smoking is a significant risk factor for lung cancer, and patients undergoing lung cancer treatments may also require oxygen therapy to manage symptoms and side effects. As the global incidence of lung cancer continues to rise due to smoking habits, the demand for oxygen therapy equipment, such as oxygen concentrators and oxygen masks, is likely to increase in tandem. The increase in tobacco smoking-related health conditions underscores the vital role that oxygen therapy equipment plays in managing and improving the lives of affected individuals. As smoking-related respiratory diseases continue to pose a significant global health challenge, the demand for oxygen therapy equipment is expected to grow, necessitating ongoing advancements and innovations in this critical medical field.

Rising Prevalence of Respiratory Diseases

The rising prevalence of respiratory diseases is expected to drive a significant increase in the demand for oxygen therapy equipment, marking a crucial facet of modern healthcare. Respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and interstitial lung diseases are on the rise globally, and they often necessitate the use of oxygen therapy to manage symptoms and improve patients' quality of life.

Chronic respiratory conditions like COPD have become a major public health concern, particularly due to factors such as air pollution, smoking, and an aging population. Patients with COPD often experience difficulty in breathing and require supplemental oxygen to maintain adequate blood oxygen levels. This growing demographic has led to an increased demand for oxygen concentrators, portable oxygen tanks, and other oxygen delivery systems.

Asthma, another common respiratory ailment, affects millions of people worldwide, and severe asthma attacks can lead to oxygen deprivation. Oxygen therapy is often crucial in stabilizing patients during acute asthma exacerbations, further contributing to the demand for oxygen-related equipment. The COVID-19 pandemic also highlighted the importance of oxygen therapy equipment as hospitals worldwide faced surges in patients with severe respiratory symptoms. This emphasized the necessity for having adequate oxygen infrastructure in healthcare facilities, further underscoring the demand for oxygen concentrators and ventilators.

Furthermore, as healthcare trends shift towards home-based care and telemedicine, the demand for portable and user-friendly oxygen therapy equipment for patients managing chronic respiratory conditions at home is increasing.

Technological Advancement in Oxygen Therapy

Technological advancements in the field of oxygen therapy are poised to revolutionize the healthcare industry, driving an unprecedented surge in the demand for oxygen therapy equipment. These innovations are not only improving the efficacy of treatment but also enhancing patient comfort and accessibility, thus reshaping the landscape of respiratory care.

One significant development is the proliferation of portable oxygen concentrators (POCs) that offer patients the freedom to receive oxygen therapy while on the move. These lightweight and compact devices are equipped with advanced battery technology, ensuring extended runtime, and they allow patients to maintain an active lifestyle, contributing to an increased quality of life. As the aging population continues to grow, the demand for POCs is expected to soar, as they enable seniors to remain independent and engaged in their communities.

Moreover, telemedicine and remote monitoring solutions have emerged as powerful tools in oxygen therapy management. The integration of smart sensors and wireless connectivity enables healthcare professionals to remotely track patients' oxygen levels, adjust treatment plans in real-time, and provide immediate support when necessary. This not only enhances the overall patient experience but also reduces the burden on healthcare facilities and staff.

Key Market Challenges

Stringent Regulatory Guidelines

Stringent regulatory guidelines in the healthcare industry have the potential to significantly decrease the demand for oxygen therapy equipment. While regulations are essential for ensuring patient safety and treatment efficacy, an excessively complex or burdensome regulatory environment can create obstacles that hinder innovation, drive up costs, and limit market access for manufacturers and healthcare providers. Rigorous regulatory processes can slow down the introduction of new and improved oxygen therapy equipment to the market. This delay can have serious consequences, as patients may miss out on potentially more effective treatments or innovations that enhance their quality of life. Healthcare providers may also be discouraged from adopting new technologies due to the uncertainties and complexities associated with regulatory approval, further stifling demand.

Additionally, stringent guidelines can lead to a limited selection of available equipment, reducing competition and innovation within the industry. This lack of variety can result in fewer options for patients and healthcare professionals, making it harder to find solutions that best meet individual needs. While regulatory guidelines are crucial for ensuring patient safety and treatment effectiveness, excessively stringent regulations can create barriers that diminish the demand for oxygen therapy equipment. Striking the right balance between regulation and innovation is essential to ensure that patients have access to the most advanced and affordable respiratory care solutions.

Frequent Adverse Effects

The market expansion for oxygen treatment is being constrained by their unfavorable side effects, which, when used therapeutically, include skin irritation and nasal dryness. Dryness of the nose and skin irritation are two of the most typical side effects of oxygen therapy. The cannula may rub against the skin and create irritation.

Moreover, prolonged exposure to high oxygen concentrations can lead to an increased risk of oxygen toxicity, which can seriously harm not only the lungs but also other organ systems. Inappropriate or excessive supplemental oxygen can result in oxygen toxicity, causing detrimental effects on lung function and overall health. This can potentially lead to lung injury and impair the body's ability to effectively exchange gases.

Additionally, the range of lung ailments that can be induced by oxygen therapy extends beyond minor tracheobronchitis to include widespread alveolar damage. The excessive production of free radicals due to long-term exposure to high oxygen concentrations can further contribute to lung injury and hinder the overall effectiveness of oxygen therapy.

Considering these factors, it becomes evident that the presence of such side effects and potential risks associated with oxygen therapy may pose challenges in the expansion of the oxygen therapy equipment market.

Key Market Trends

Technology Advancements in Therapeutic Equipment

Due to the significant increase in the number of individuals with respiratory conditions who rely on oxygen therapy devices (OTD), healthcare facilities are facing immense pressure to effectively manage patients who require constant OTD support. This growing demand is driving the market for oxygen therapy solutions. As wearable technology continues to advance, with notable improvements in Photoplethysmography (PPG) sensors and wireless 5G connectivity, it is expected that the trend of **digital health** data transfer for oxygen therapy monitoring will experience rapid growth.

PPG, a non-invasive device, accurately measures volumetric fluctuations in blood circulation by utilizing a light source and a photodetector placed on the skin's surface. Wearable PPG sensors can be comfortably accommodated on specific body parts such as fingertips, earlobes, and the forehead. Moreover, with the increasing utilization and adoption of remote patient monitoring systems, patients are becoming more actively engaged in their own care, thanks to proper instruction in the use of these systems. These advancements and patient involvement hold promising prospects for the market's growth and profitability.

Advanced Portable Oxygen Solutions

Portable oxygen concentrators (POCs) and lightweight, wearable devices will continue to evolve. These innovations will allow patients to receive oxygen therapy while maintaining an active lifestyle and even traveling, contributing to a better quality of life. POCs will continue to become smaller and lighter, making them highly portable. These devices will be easier to carry in backpacks or even wear as discreet accessories. Patients will have the freedom to move around without the burden of bulky equipment.

Battery technology will advance, providing POCs with longer runtime. This means patients can go longer periods without needing to recharge or replace their batteries, making travel and outdoor activities more practical. POCs will feature wireless connectivity options, allowing for remote monitoring by healthcare providers and caregivers. Real-time data on oxygen levels and usage patterns can be transmitted, enabling timely adjustments to treatment plans and better support. These advancements will collectively empower patients to lead more active and fulfilling lives while managing their oxygen therapy needs. With greater portability, convenience, and connectivity, patients will be better equipped to maintain an active lifestyle, travel, and participate in a wide range of activities, ultimately contributing to an improved quality of life for individuals with respiratory conditions.

Segmental Insights

Mobility Insights

Based on the mobility segment, the stationary oxygen therapy equipment devices is projected to dominate the market in terms of portability. This is primarily due to the fact that a significant number of patients receiving treatment are confined to beds, thus making the fixed oxygen therapy equipment market the key driver and contributor to maximum market revenue throughout the projection period.

The expansion of this category can be attributed to several factors, including a rising population base, favourable reimbursement policies, and a low mobility profile of patients. As a result, there is an increased demand for long-term oxygen therapy (LTOT) equipment in residential settings, which is expected to further boost the overall demand for oxygen therapy equipment over the projected period. The utilization of LTOT equipment in residential settings not only provides enhanced convenience and comfort for patients but also contributes to the overall improvement in their quality of life.

Application Insights

Based on the Application, the market is bifurcated into Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Pneumonia, COVID-19, and others. Among these, the Chronic Obstructive Pulmonary Disorder (COPD) segment dominates the market with the largest share, owing to the increasing prevalence of COPD worldwide. According to estimates by the World Health Organization (WHO), approximately 65 million individuals are currently suffering from COPD, making it the fifth-leading cause of death globally. This alarming statistic highlights the urgent need for effective COPD therapy and creates a significant clinical demand in the market, which in turn contributes to the growth of companies operating in this domain. With the rising prevalence of COPD, there is an increasing focus on developing innovative treatment solutions to address this chronic respiratory disorder and improve the quality of life for affected individuals.

Regional Insights

During the forecast period, North America is anticipated to maintain its dominance in the global oxygen therapy equipment market. This is attributed to the increasing prevalence of respiratory diseases like COPD, asthma, and carbon monoxide poisoning. Additionally, the rising number of Covid-19 cases in the region is expected to drive the demand for oxygen therapy equipment in the coming years.

Moreover, the United States holds the largest share in the global oxygen therapy equipment market, mainly due to its well-established healthcare infrastructure and the growing adoption of advanced non-invasive patient monitoring technologies. Furthermore, the presence of key market players such as Koninklijke Philips N.V., Invacare Corporation, and Inogen, Inc. is expected to further propel the oxygen therapy equipment market.

Considering various factors, including a sizable patient population and the introduction of new products in the region, the North American oxygen therapy equipment market is projected to witness significant growth during the forecast period.

Key Market Players

• Allied Healthcare Products, Inc.

• CAIRE Inc.

• DeVilbiss Healthcare

• Fisher & Paykel Healthcare Limited

• Inogen Inc.

• Invacare Corporation

• Koninklijke Philips N.V.,

• Smith's Medical, Inc.

• Taiyo Nippon Sanso Corporation

• Linde Healthcare

Report Scope:

In this report, the Global Oxygen Therapy Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oxygen Therapy Equipment Market, By Product Type:

• Oxygen Source Equipment
• Oxygen Delivery Devices

Oxygen Therapy Equipment Market, By Mobility:

• Stationary
• Portable

Oxygen Therapy Equipment Market, By Application:

• COPD
• Lung Cancer
• Pneumonia
• COVID-19
• Others

Oxygen Therapy Equipment Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centres
• Homecare
• Others

Oxygen Therapy Equipment Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Oxygen Therapy Equipment Market.

Available Customizations:

• Global Oxygen Therapy Equipment market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oxygen Therapy Equipment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Oxygen Source Equipment v/s Oxygen Delivery Devices)
    • 5.2.1.1. By Oxygen Source Equipment (Oxygen Cylinders, Oxygen Concentrators, Liquid Oxygen Devices, Others)
    • 5.2.1.2. By Oxygen Delivery Devices (Oxygen Masks, Nasal Cannula, Non-Rebreather Masks, Others)
  • 5.2.2. By Mobility (Stationary v/s Portable)
  • 5.2.3. By Application (COPD, Lung Cancer, Pneumonia, COVID-19, Others)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Homecare, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2022)
• 5.3. Market Map

6. North America Oxygen Therapy Equipment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Mobility
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Oxygen Therapy Equipment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Mobility
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Oxygen Therapy Equipment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Mobility
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Oxygen Therapy Equipment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Mobility
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Oxygen Therapy Equipment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Mobility
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Oxygen Therapy Equipment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Mobility
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Oxygen Therapy Equipment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Mobility
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Oxygen Therapy Equipment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Mobility
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. France Oxygen Therapy Equipment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Mobility
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Oxygen Therapy Equipment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Mobility
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Oxygen Therapy Equipment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Mobility
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Oxygen Therapy Equipment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Mobility
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Oxygen Therapy Equipment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Mobility
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Oxygen Therapy Equipment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Mobility
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Oxygen Therapy Equipment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Mobility
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Oxygen Therapy Equipment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Mobility
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Oxygen Therapy Equipment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Mobility
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Oxygen Therapy Equipment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Mobility
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Oxygen Therapy Equipment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Mobility
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Oxygen Therapy Equipment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Mobility
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Oxygen Therapy Equipment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Mobility
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Oxygen Therapy Equipment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Mobility
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Oxygen Therapy Equipment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Mobility
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Oxygen Therapy Equipment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Mobility
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Oxygen Therapy Equipment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Allied Healthcare Products, Inc.
  • 15.5.2. CAIRE Inc.
  • 15.5.3. DeVilbiss Healthcare
  • 15.5.4. Fisher & Paykel Healthcare Limited
  • 15.5.5. Inogen Inc.
  • 15.5.6. Invacare Corporation
  • 15.5.7. Koninklijke Philips N.V.,
  • 15.5.8. Smiths Medical, Inc.
  • 15.5.9. Taiyo Nippon Sanso Corporation
  • 15.5.10. Linde Healthcare

16. Strategic Recommendations

17. About Us & Disclaimer